Anpario (LON:ANP) Rating Increased to Buy at Canaccord Genuity Group

Anpario (LON:ANP) was upgraded by equities research analysts at Canaccord Genuity Group to a “buy” rating in a report issued on Thursday,London Stock Exchange reports. The brokerage presently has a GBX 570 price objective on the stock, up from their previous price objective of GBX 457. Canaccord Genuity Group’s target price suggests a potential upside of 22.61% from the company’s previous close.

Separately, Shore Capital Group reaffirmed a “house stock” rating on shares of Anpario in a research note on Monday, January 19th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of GBX 570.

Anpario Stock Performance

ANP opened at GBX 464.90 on Thursday. The business has a 50 day moving average price of GBX 511.68 and a two-hundred day moving average price of GBX 496.76. The company has a debt-to-equity ratio of 0.22, a current ratio of 4.32 and a quick ratio of 5.16. The company has a market capitalization of £78.78 million, a price-to-earnings ratio of 15.64 and a beta of 0.92. Anpario has a 1-year low of GBX 286 and a 1-year high of GBX 580.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.